Christoph Correll to Middle Aged
This is a "connection" page, showing publications Christoph Correll has written about Middle Aged.
Connection Strength
0.129
-
Successful switching of patients with acute schizophrenia from another antipsychotic to brexpiprazole: comparison of clinicians' choice of cross-titration schedules in a post hoc analysis of a randomized, double-blind, maintenance treatment study. CNS Spectr. 2019 10; 24(5):507-517.
Score: 0.013
-
Social and functional outcomes with two doses of aripiprazole lauroxil vs placebo in patients with schizophrenia: a post-hoc analysis of a 12-week phase 3 efficacy study. Psychiatry Res. 2019 04; 274:176-181.
Score: 0.013
-
ECT augmentation of clozapine for clozapine-resistant schizophrenia: A meta-analysis of randomized controlled trials. J Psychiatr Res. 2018 10; 105:23-32.
Score: 0.012
-
Effectiveness of Long-Acting Injectable vs Oral Antipsychotics in Patients With Schizophrenia: A Meta-analysis of Prospective and Retrospective Cohort Studies. Schizophr Bull. 2018 04 06; 44(3):603-619.
Score: 0.012
-
Tardive Dyskinesia: Recognition, Patient Assessment, and Differential Diagnosis. J Clin Psychiatry. 2018 Mar/Apr; 79(2).
Score: 0.012
-
The Validity and Sensitivity of PANSS-6 in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Study. Schizophr Bull. 2018 02 15; 44(2):453-462.
Score: 0.012
-
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder. Psychopharmacol Bull. 2017 08 01; 47(3):53-60.
Score: 0.012
-
Psychosis breakthrough on antipsychotic maintenance: results from a nationwide study. Psychol Med. 2020 06; 50(8):1356-1367.
Score: 0.003
-
Network analysis of the relationship between depressive symptoms, demographics, nutrition, quality of life and medical condition factors in the Osteoarthritis Initiative database cohort of elderly North-American adults with or at risk for osteoarthritis. Epidemiol Psychiatr Sci. 2019 02 06; 29:e14.
Score: 0.003
-
Age Impacts Olanzapine Exposure Differently During Use of Oral Versus Long-Acting Injectable Formulations: An Observational Study Including 8,288 Patients. J Clin Psychopharmacol. 2018 Dec; 38(6):570-576.
Score: 0.003
-
Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole: a 6-month, real-life non-interventional study. BMC Psychiatry. 2018 11 14; 18(1):365.
Score: 0.003
-
Sex and body weight are major determinants of venlafaxine pharmacokinetics. Int Clin Psychopharmacol. 2018 11; 33(6):322-329.
Score: 0.003
-
Glucagon-like peptide-1 receptor agonists for antipsychotic-associated cardio-metabolic risk factors: A systematic review and individual participant data meta-analysis. Diabetes Obes Metab. 2019 02; 21(2):293-302.
Score: 0.003
-
Inter-rater reliability of ratings on the six-item Positive and Negative Syndrome Scale (PANSS-6) obtained using the Simplified Negative and Positive Symptoms Interview (SNAPSI). Nord J Psychiatry. 2018 Aug; 72(6):431-436.
Score: 0.003
-
Antipsychotic Medication Treatment Patterns in Adult Depression. J Clin Psychiatry. 2018 Mar/Apr; 79(2).
Score: 0.003
-
Leptin and Physical Activity in Adult Patients with Anorexia Nervosa: Failure to Demonstrate a Simple Linear Association. Nutrients. 2017 11 03; 9(11).
Score: 0.003
-
The Effects of Valbenazine in Participants with Tardive Dyskinesia: Results of the 1-Year KINECT 3 Extension Study. J Clin Psychiatry. 2017 Nov/Dec; 78(9):1344-1350.
Score: 0.003
-
Evaluating the Effect of the Changes in FDA Guidelines for Clozapine Monitoring. J Clin Psychiatry. 2017 Sep/Oct; 78(8):e933-e939.
Score: 0.003
-
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder. Psychopharmacol Bull. 2017 08 01; 47(3):69-76.
Score: 0.003
-
Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity in Clozapine- or Olanzapine-Treated Patients With Schizophrenia Spectrum Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2017 07 01; 74(7):719-728.
Score: 0.003
-
Child and adolescent psychiatrists' reported monitoring behaviors for second-generation antipsychotics. J Child Adolesc Psychopharmacol. 2015 May; 25(4):351-61.
Score: 0.002